The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
Forum Comments on Share Price

Related Posts

Nextech3D.ai Announces Closing of First Tranche of Private...

November 16, 2023

Silver Price Update: Q1 2024 in Review

April 25, 2024

Drilling to Commence at Big Bell North Gold...

October 9, 2024

Resignation of Managing Director/CEO

July 21, 2025

GM Strengthens Lithium Supply Chain with US$625 Million...

October 19, 2024

5 Top Weekly TSXV Stocks: NorthWest Copper Leads...

January 2, 2024

NextSource Materials Closes Private Placement for Gross Proceeds...

October 12, 2024

Canadian Critical Minerals Closes Financing

May 16, 2024

Pinnacle Changes OTC Ticker Symbol to PSGCF

July 4, 2025

Danielle DiMartino Booth: US Economy at Precipice —...

March 28, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,511)
    • Investing (3,924)
    • Politics (5,236)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved